Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trialLajos Pusztai, Laura J. Esserman, Christina Yau et al.|Cancer Cell|2021Cited by 330
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancerDavid B. Page, Sylvia Adams, Harry D. Bear et al.|npj Breast Cancer|2019Cited by 86
Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasisDaniel Doheny, Hui‐Wen Lo, Michael D. Chan et al.|Oncogene|2020Cited by 83
RETRACTED: Actively Targeted Nanodelivery of Echinomycin Induces Autophagy-Mediated Death in Chemoresistant Pancreatic Cancer In VivoAlexandra Thomas, Lacey R. McNally|Cancers|2020Cited by 18
The role of medical schools in UK students’ career intentions: findings from the AIMS studyTomás Ferreira, Luke Dcaccia, Alexander M Collins et al.|BMC Medical Education|2024Cited by 7